Saturday, June 21, 2025

Bausch Health Unveils Advanced Fraxel FTX™ at ASLMS 2025 Conference

Similar articles

Bausch Health Companies Inc., alongside Solta Medical, introduced the next-generation Fraxel FTX™ laser system at the American Society for Laser Medicine & Surgery’s 2025 Annual Conference in Orlando. This debut marks the beginning of the product’s distribution to US-based dermatologists and aesthetic professionals, with global expansion on the horizon.

Innovative Skin Resurfacing Technology

Fraxel FTX™ builds upon the renowned Fraxel® platform, enhancing skin rejuvenation treatments for concerns like sun damage, wrinkles, and acne scars. The system’s dual-wavelength fractional laser offers precise targeting of skin layers, promoting quicker healing and improved patient comfort.

Subscribe to our newsletter

Enhanced Features for Professionals and Patients

The redesigned ergonomic handpiece reduces device weight by 20%, integrates cooling technology, and ensures a more comfortable experience for patients. Additionally, the updated user interface and intelligent optical tracking enable practitioners to deliver consistent, effective treatments tailored to individual skin types.

  • Improved ergonomic design enhances practitioner ease and patient comfort.
  • Dual-wavelength technology targets multiple skin layers for comprehensive treatment.
  • Intelligent Optical Tracking® with AccuTRAC™ ensures efficient and precise laser delivery.

Fraxel FTX™ is expected to significantly impact aesthetic practices by offering noticeable skin improvements with minimal downtime. Its advanced features aim to increase patient satisfaction and streamline treatment workflows for healthcare professionals.

Healthcare providers adopting Fraxel FTX™ can leverage its cutting-edge technology to meet the growing demand for effective skin rejuvenation solutions. The system’s superior design and functionality not only enhance treatment outcomes but also support the operational efficiency of aesthetic clinics.

As Bausch Health continues to innovate in the aesthetic medicine sector, Fraxel FTX™ stands out as a testament to the company’s commitment to quality and advanced patient care. This launch underscores the strategic vision to provide healthcare professionals with top-tier tools that deliver exceptional results, reinforcing Bausch Health’s position as a leader in the pharmaceutical and aesthetic industries.

Source


This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.

Latest article